The Patent Offices of Ronald B. Goldstein (formerly Priest & Goldstein, PLLC) is a boutique intellectual property firm with an emphasis on patents. Our practice concentrates on assisting clients with the acquisition, protection and exploitation of patent assets, including patent preparation and prosecution.
In addition, the firm advises clients on transactions involving the acquisition, development, protection and commercialization of technology.
Ronald B. Goldstein
Ron Goldstein is a highly experienced patent agent, having previously practiced intellectual property law since 1987, including experience as the Vice President, Patents and Licensing for Pharmacopeia, Inc., where he was responsible for the company’s patent portfolio, as well as the negotiation of collaborative research and license agreements with a total "BioWorld" value of more than $250 million dollars.
Before joining Pharmacopeia, Ron was the first in-house counsel at Sepracor, Inc. (the predecessor of Sunovion Pharmaceuticals), where he was responsible for all patent prosecution, out-licensing and patent infringement litigation.
Ron is registered to practice before the U.S. Patent and Trademark Office, and is a former member of the Bar in New York, in New Jersey, and in the U.S. Court of Appeals for the Federal Circuit.
Prior to his legal career, Ron worked as a chemical engineer at Celanese Chemical Company. Ron received Bachelor of Science Degrees in Chemical Engineering and in Biology from Massachusetts Institute of Technology, and a Master of Business Administration and Juris Doctor with Honors from the University of Texas at Austin.
Ron’s practice includes patent prosecution, due diligence, opinion work and counseling in technology areas such as combinatorial chemistry, molecular biology, high-throughput screening, biological assays and reagents, molecular modeling and informatics for both start-ups and multinational corporations. Ron previously represented numerous small companies in transactions to establish research and technology collaborations with larger companies and universities.
